PIE Comments to the Food and Drug Administration
Docket No. FDA-2025-N-6895, Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments, Bulk Drug Substances Nominated for Inclusion on the Section 503A Bulk Drug Substances List
PIE Comments to DHHS
Comments in Support of the 2026 CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule (CMS-0062-P)
PIE Letter to Senate HELP Committee-Support for 340B Reform
PIE prepared and forwarded this letter to the two ranking members of the Senate HELP Committee to show our support for the HEC coalition's specific 340B reform efforts to be discussed at the committee's hearing on October 23, 2025
PIE Partner HEC Infographic - 340B Reform
PIE Partner Health Equity Collaborative prepared this infographic to help educate elected officials and community leaders on the more important aspects of our 340B reform efforts
PIE Letter to Congress
Please Protect the Integrity of the 340B Program – Oppose the 340B PATIENTS Act